The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | C | Cardiovascular system | |
2 | C10 | Lipid modifying agents | |
3 | C10A | Lipid modifying agents, plain | |
4 | C10AC | Bile acid sequestrants |
Code | Title | |
---|---|---|
C10AC01 | Colestyramine | |
C10AC02 | Colestipol | |
C10AC03 | Colextran | |
C10AC04 | Colesevelam |
Active Ingredient | Description | |
---|---|---|
Colesevelam |
Colesevelam is a non-absorbed, lipid-lowering polymer that binds bile acids in the intestine, impeding their reabsorption. |
|
Colestipol |
Colestipol is an ion exchange resin which lowers plasma cholesterol through binding with bile acids in the intestinal lumen. It is indicated as adjunctive therapy to diet in the management of patients with elevated cholesterol levels who have not responded adequately to diet. |
|
Colestyramine |
Colestyramine resin absorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the faeces. This results in an increased faecal loss of bile acids which leads to an increased oxidation of cholesterol to bile acids and a decrease in serum cholesterol levels and low density lipoprotein serum levels. |
Title | Information Source | Document Type | |
---|---|---|---|
CHOLESTAGEL Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
COLESTID Granule for oral suspension | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
COLESTID Granule for oral suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
COLESTID Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
OLESTYR Oral suspension | Health Products and Food Branch (CA) | MPI, CA: SPM | |
QUESTRAN Powder for oral suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |